These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2546642)

  • 1. Carcinoma of the prostate.
    Ritchie AW
    Br J Hosp Med; 1989 Jun; 41(6):568-73. PubMed ID: 2546642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of urological malignancy: the prostate.
    Doherty AP; Christmas TJ
    Br J Hosp Med; 1996 Feb 7-20; 55(3):104-6, 123-4. PubMed ID: 8907872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, diagnosis and treatment of prostate cancer.
    Newman J
    Radiol Technol; 1996; 68(1):39-64; quiz 65-8. PubMed ID: 8880970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base.
    Miller DC; Hafez KS; Stewart A; Montie JE; Wei JT
    Cancer; 2003 Sep; 98(6):1169-78. PubMed ID: 12973840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnosis and staging of prostatic carcinoma.
    Alcini E; D'Addessi A
    Rays; 1993; 18(1):3-13. PubMed ID: 7689236
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma].
    Recker F
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1881-90. PubMed ID: 8984601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small cell prostatic carcinoma. Presentation of diagnosis, therapy and prognosis based on a case report].
    Munker R; Schalhorn A
    Fortschr Med; 1994 Nov; 112(33):473-5. PubMed ID: 7843670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
    Pappas AA; Gadsden RH
    Ann Clin Lab Sci; 1984; 14(4):285-91. PubMed ID: 6465831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer of the prostate. Diagnosis, prognosis, principles of treatment].
    Lopez JG; Perrin P
    Rev Prat; 1999 Feb; 49(3):297-301. PubMed ID: 10189800
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of prostate cancer.
    Hernandez J; Thompson IM
    Med Clin North Am; 2004 Mar; 88(2):267-79, ix. PubMed ID: 15049578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment.
    Gjengstø P; Eide J; Frugård J; Bakke A; Høisaeter PA
    Scand J Urol Nephrol; 2004; 38(1):15-8. PubMed ID: 15204421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer: a urological perspective.
    Fradet Y
    Can J Oncol; 1994 Nov; 4 Suppl 1():8-12. PubMed ID: 8853480
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
    Celko AM
    Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostate specific antigen (PSA): impact of a seric marker on the diagnosis and therapeutic management of cancers of the prostate].
    Chauvet B; Jacob T; Davin JL; Berger C; Vincent P; Reboul F
    Bull Cancer Radiother; 1996; 83(4):334-44. PubMed ID: 9081335
    [No Abstract]   [Full Text] [Related]  

  • 20. Current concepts in the management of prostatic cancer.
    Schröder FH
    Am J Clin Oncol; 1988; 11 Suppl 1():S1-5. PubMed ID: 3389335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.